Santen Pharmaceutical Co., Ltd.Santen Pharmaceutical Co., Ltd.Santen Pharmaceutical Co., Ltd.

Santen Pharmaceutical Co., Ltd.

No trades
See on Supercharts
Next report date
Report period
Q4 2023
EPS estimate
0.12USD
Revenue estimate
‪522.87 M‬USD
Market capitalization
‪3.48 B‬USD
‪−112.57 M‬USD
‪2.10 B‬USD
‪312.65 M‬
Beta (1Y)
0.31

About Santen Pharmaceutical Co., Ltd.

CEO
Takeshi Ito
Headquarters
Osaka
Employees (FY)
‪4.14 K‬
Founded
1890
ISIN
JP3336000009
FIGI
BBG000DQQM00
Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. It operates through the following segments: Pharmaceuticals and Others. The Pharmaceuticals segment includes prescription ophthalmic drugs, anti-rheumatic pharmaceuticals, and over-the-counter products. The Others segment offers medical equipment and devices. The company was founded by Kenkichi Tagushi in 1890 and is headquartered in Osaka, Japan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of SNPHF is 9.26 USD — it has decreased by 1.99% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Santen Pharmaceutical Co., Ltd. stocks are traded under the ticker SNPHF.
Santen Pharmaceutical Co., Ltd. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
SNPHF stock is 2.03% volatile and has beta coefficient of 0.31. Check out the list of the most volatile stocks — is Santen Pharmaceutical Co., Ltd. there?
SNPHF earnings for the last quarter are 0.16 USD per share, whereas the estimation was 0.09 USD resulting in a 82.94% surprise. The estimated earnings for the next quarter are 0.12 USD per share. See more details about Santen Pharmaceutical Co., Ltd. earnings.
Santen Pharmaceutical Co., Ltd. revenue for the last quarter amounts to ‪491.31 M‬ USD despite the estimated figure of ‪442.04 M‬ USD. In the next quarter revenue is expected to reach ‪522.31 M‬ USD.
Yes, you can track Santen Pharmaceutical Co., Ltd. financials in yearly and quarterly reports right on TradingView.
SNPHF stock has fallen by 1.99% compared to the previous week, the month change is a 1.99% fall, over the last year Santen Pharmaceutical Co., Ltd. has showed a 13.15% increase.
SNPHF net income for the last quarter is ‪51.93 M‬ USD, while the quarter before that showed ‪59.33 M‬ USD of net income which accounts for −12.48% change. Track more Santen Pharmaceutical Co., Ltd. financial stats to get the full picture.
Today Santen Pharmaceutical Co., Ltd. has the market capitalization of ‪3.37 B‬, it has decreased by 1.69% over the last week.
Like other stocks, SNPHF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Santen Pharmaceutical Co., Ltd. stock right from TradingView charts — choose your broker and connect to your account.
SNPHF reached its all-time high on Mar 6, 2015 with the price of 70.12 USD, and its all-time low was 6.25 USD and was reached on Nov 8, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 26, 2024, the company has ‪4.14 K‬ employees. See our rating of the largest employees — is Santen Pharmaceutical Co., Ltd. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Santen Pharmaceutical Co., Ltd. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Santen Pharmaceutical Co., Ltd. stock shows the sell signal. See more of Santen Pharmaceutical Co., Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Santen Pharmaceutical Co., Ltd. future price: according to them, SNPHF price has a max estimate of 14.17 USD and a min estimate of 8.37 USD. Read a more detailed Santen Pharmaceutical Co., Ltd. forecast: see what analysts think of Santen Pharmaceutical Co., Ltd. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Santen Pharmaceutical Co., Ltd. EBITDA is ‪503.21 M‬ USD, and current EBITDA margin is 17.66%. See more stats in Santen Pharmaceutical Co., Ltd. financial statements.